A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Synonyms: 70359-46-5, 79570-19-7, AGN190342, 59803-99-5, Alphagan, UK 14,30418, Ratio-Brimonidine, Bromoxidine, Brimonidine, 4S9CL2DY2H, UK 14,304-18, Brimonidine Tartrate (1:1), UK14,308, 5-bromo-6-(imidazolin-2-ylamino)quinoxaline, 5-bromo-6-(imidazolidinylideneamino)quinoxaline, Mirvaso, UK 14,304 18, Brimonidine Purite, Sanrosa, AGN-190342, UK14304, Alphagan P, Brimonidine Tartrate, E6GNX3HHTE, UK14,30418, 6-quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1), Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer, Ratio Brimonidine, 0, UK-14,308, UK-14304, UK 14308, Brimonidine Tartrate, (R-(R*,R*))-Isomer, UK 14304, 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate, AGN 190342, UK 14,308, UK-14,304-18, UK 14,304